Three new lanostanoids from the mushroom Ganoderma tropicum
Shuang-Shuang Zhang1, Yu-Guang Wang2, Qing-Yun Ma3
1College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China. 2012208021@njau.edu.cn.
Molecules (Basel, Switzerland)
|February 19, 2015
Summary
Three novel lanostanoid triterpenes were identified in the mushroom Ganoderma tropicum. These compounds, ganotropic acid and two related acids, were structurally characterized using advanced spectroscopic methods.
Area of Science:
- Natural Product Chemistry
- Mycology
- Organic Chemistry
Background:
- Mushrooms, particularly those from the Ganoderma genus, are known sources of bioactive compounds.
- Triterpenes, a class of natural products, exhibit diverse pharmacological properties.
- Ganoderma tropicum is a fungal species with potential for novel compound discovery.
Purpose of the Study:
- To isolate and characterize new lanostanoid triterpenes from Ganoderma tropicum.
- To elucidate the chemical structures of these novel compounds.
Main Methods:
- Extraction of fruiting bodies of Ganoderma tropicum using n-butanol.
- Isolation of compounds using chromatographic techniques.
- Structure elucidation via 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy.
- High-Resolution Electron Ionization Mass Spectrometry (HR-EI-MS) for structural confirmation.
Main Results:
- Three new lanostanoid triterpenes were successfully isolated and identified.
- Compound 1 was named ganotropic acid.
- Compounds 2 and 3 are novel hydroxylated and oxidized lanostanoid derivatives.
Conclusions:
- The study expands the known chemical diversity of lanostanoid triterpenes.
- Ganoderma tropicum is confirmed as a source of structurally unique natural products.
- The identified compounds represent potential leads for further pharmacological investigation.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.3K
01:15Antifungal Agents
100
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
100
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.3K
01:15Drugs that Stabilize Microtubules
2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
2.1K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.4K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.4K